Stiff person syndrome

Frontiers of Neurology and Neuroscience

Volumn 26, Issue , 2009, Pages 147-165

  Duddy, Martin E ^a   Baker, Mark R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR ASSOCIATED PROTEIN ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CYCLOPHOSPHAMIDE; ETIRACETAM; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROPOFOL; PROTEIN ANTIBODY; RITUXIMAB; STEROID; TIAGABINE; UNCLASSIFIED DRUG; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2;

ANTIBODY BLOOD LEVEL; ATAXIA; AUTOIMMUNITY; AUTONOMIC DYSFUNCTION; CEREBELLUM DEGENERATION; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; ENCEPHALOMYELITIS; GABAERGIC SYSTEM; HOSPITAL ADMISSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTENSIVE CARE; INVOLUNTARY MOVEMENT; METABOLIC ACIDOSIS; MORTALITY; MOTOR ACTIVITY; MUSCLE DISEASE; MUSCLE SPASM; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS; REVIEW; RIGIDITY; STIFF LIMB SYNDROME; STIFF MAN SYNDROME; SUDDEN DEATH; TISSUE SPECIFICITY; IMMUNOLOGY;

GLUTAMATE DECARBOXYLASE; HUMANS; PROGNOSIS; STIFF-PERSON SYNDROME;

EID: 67649745882     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000212375     Document Type: Review

References (138)

1. Thorburn W: Cases of injury to the cervical region of the spinal cord. Brain 1887;9:510-543.
2. Babinski J: Contracture liée à une irritation des cornes antérieures de la moelle dans un cas de syringo-myélie. Rev Neurol 1913;1:246-249.
3. Tarlov IM: Rigidity in man due to spinal interneuron loss. Arch Neurol 1967;16:536-543.
4. Penry JK, Hoefnagel D, Van Den Noort S, Dennybrown D: Muscle spasm and abnormal postures resulting from damage to interneurones in spinal cord. Arch Neurol 1960;3:500-512.
5. Martinelli P, Montagna P, Pazzaglia P, Coccagna G: Electrophysiological findings in a case of stiff man syndrome associated with epilepsy and nocturnal myoclonus. Riv Neurol 1978;48:479-491.
6. HM, Ricker K, Conrad B: The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine. J Neurol Neurosurg Psychiatry 1984;47:280-287.
7. Schmierer K, Valdueza JM, Bender A, DeCamilli P, David C, Solimena M, Zschenderlein R: Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology 1998;51:250-252.
8. Matsumoto JY, Caviness JN, McEvoy KM: The acoustic startle reflex in stiff-man syndrome. Neurology 1994;44:1952-1955.
9. Moersch F P, Woltman HW: Progressive fluctuating muscular rigidity and spasm ('stiff-man' syndrome); report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin 1956;31:421-427.
10. Rushworth G, Lishman WA, Hughes JT, Oppenheimer DR: Intense rigidity of the arms due to isolation of motoneurones by a spinal tumour. J Neurol Neurosurg Psychiatry 1961;24:132-142.
11. Lourie H: Spontaneous activity of alpha motor neurons in intramedullary spinal cord tumor. J Neurosurg 1968;29:573-580.
12. Gelfan S, Tarlov IM: Interneurones and rigidity of spinal origin. J Physiol 1959;146:594-617.
13. Sandbrink F, Syed NA, Fujii MD, Dalakas MC, Floeter MK: Motor cortex excitability in stiff-person syndrome. Brain 2000;123:2231-2239.
14. Koerner C, Wieland B, Richter W, Meinck HM: Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-gad autoimmunity. Neurology 2004;62:1357-1362.
15. Bhatt AD, Dastur FD: Relapsing tetanus (a case report). J Postgrad Med 1981;27:184-186.
16. Meinck HM, Thompson PD: Stiff man syndrome and related conditions. Mov Disord 2002;17:853-866.
17. Walshe FMR: On the symptom complexes of lethargic encephalitis with special reference to involuntary muscular contractions. Brain 1920;43:197-219.
18. Meinck HM, Ricker K, Hulser PJ, Solimena M: Stiff man syndrome: neurophysiological findings in eight patients. J Neurol 1995;242:134-142.
19. Hardin JA, Griggs RC: Diazepam treatment in a case of strychnine poisoning. Lancet 1971;ii:372-373.
20. Molloy FM, Dalakas MC, Floeter MK: Increased brainstem excitability in stiff-person syndrome. Neurology 2002;59:449-451.
21. Barker RA, Revesz T, Thom M, Marsden CD, Brown P: Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998;65:633-640.
22. Poon WT, Au KM, Chan YW, Chan KY, Chow CB, Tong SF, Lam CW: Novel missense mutation (Y279S) in the GLRA1 gene causing hyperekplexia. Clin Chim Acta 2006;364:361-362.
23. Berger C, Meinck HM: Head retraction reflex in stiff-man syndrome and related disorders. Mov Disord 2003;18:906-911.
24. Wong VC, Lam C W, Fung CW: Stiff child syndrome with mutation of DYT1 gene. Neurology 2005;65: 1465-1466.
25. Dubow JS, Zadikoff C: Isolated navicular fracture presenting as stiff limb syndrome: a case report. Mov Disord 2007;22:2136-2137.
26. Martin R, Meinck HM, Schulte-Mattler W, Ricker K, Mertens HG: Borrelia burgdorferi myelitis presenting as a partial stiff man syndrome. J Neurol 1990;237:51-54.
27. Denny-Brown D, Foley JM: Effect of poliomyelitis on the function of the motor neuron. Arch Neurol Psychiatry 1950;64:145-155.
28. Steffen H, Menger N, Richter W, Nolle B, Krastel H, Stayer C, Kolling GH, Wassle H, Meinck HM: Immune-mediated retinopathy in a patient with stiff-man syndrome. Graefes Arch Clin Exp Ophthalmol 1999;237:212-219.
29. Thompson PD: The stiff-man syndrome and related disorders. Parkinsonism Relat Disord 2001;8:147-153.
30. Taban M, Langston RH, Lowder CY: Scleritis in a person with stiff-person syndrome. Ocul Immunol Inflamm 2007;15:37-39.
31. Economides JR, Horton JC: Eye movement abnormalities in stiff person syndrome. Neurology 2005; 65:1462-1464.
32. Thomas S, Critchley P, Lawden M, Farooq S, Thomas A, Proudlock FA, Constantinescu CS, Gottlob I: Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma. J Neurol Neurosurg Psychiatry 2005;76:141-142.
33. Ances BM, Dalmau JO, Tsai J, Hasbani MJ, Galetta SL: Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies. Am J Ophthalmol 2005;140:142-144.
34. Zivotofsky AZ, Siman-Tov T, Gadoth N, Gordon CR: A rare saccade velocity profile in stiff-person syndrome with cerebellar degeneration. Brain Res 2006;1093:135-140.
35. Oskarsson B, Pelak V, Quan D, Hall D, Foster C, Galetta S: Stiff eyes in stiff-person syndrome. Neurology 2008;71:378-380.
36. Asher R: A woman with the stiff-man syndrome. Br Med J 1958;1:265-266.
37. Tinsley JA, Barth EM, Black JL, Williams DE: Psychiatric consultations in stiff-man syndrome. J Clin Psychiatry 1997;58:444-449.
38. Henningsen P, Clement U, Kuchenhoff J, Simon F, Meinck HM: Psychological factors in the diagnosis and pathogenesis of stiff-man syndrome. Neurology 1996;47:38-42.
39. Henningsen P, Meinck HM: Specific phobia is a frequent non-motor feature in stiff man syndrome. J Neurol Neurosurg Psychiatry 2003;74:462-465.
40. Ameli R, Snow J, Rakocevic G, Dalakas MC: A neuropsychological assessment of phobias in patients with stiff person syndrome. Neurology 2005;64: 1961-1963.
41. Levy LM, Levy-Reis I, Fujii M, Dalakas MC: Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol 2005;62:970-974.
42. Perani D, Garibotto V, Moresco RM, Ortelli P, Corbo M, Fazio F, Folli F: PET evidence of central GABAergic changes in stiff-person syndrome. Mov Disord 2007;22:1030-1033.
43. Floeter MK, Valls-Sole J, Toro C, Jacobowitz D, Hallett M: Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology 1998;51:85-93.
44. Warich-Kirches M, Von Bossanyi P, Treuheit T, Kirches E, Dietzmann K, Feistner H, Wittig H: Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clin Neuropathol 1997;16:214-219.
45. Mitsumoto H, Schwartzman MJ, Estes ML, Chou SM, La Franchise EF, De Camilli P, Solimena M: Sudden death and paroxysmal autonomic dysfunction in stiffman syndrome. J Neurol 1991;238:91-96.
46. Meinck HM, Ricker K, Hulser PJ, Schmid E, Peiffer J, Solimena M: Stiff man syndrome: clinical and laboratory findings in eight patients. J Neurol 1994; 241:157-166.
47. Armon C, Swanson J W, McLean JM, Westbrook PR, Okazaki H, Kurtin PJ, Kalyan-Raman UP, Rodriguez M: Subacute encephalomyelitis presenting as stiff-person syndrome: clinical, polygraphic, and pathologic correlations. Mov Disord 1996;11:701-709.
48. Schloot NC, Batstra MC, Duinkerken G, De Vries RR, Dyrberg T, Chaudhuri A, Behan PO, Roep BO: GAD65-reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun 1999;12:289-296.
49. Burns TM, Jones HR, Phillips LH 2nd, Bugawan TL, Erlich HA, Lennon VA : Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter. Neurology 2003;61:1291-1293.
50. Pugliese A, Solimena M, Awdeh ZL, Alper CA, Bugawan T, Erlich HA, De Camilli P, Eisenbarth GS: Association of HLA-DQB1*0201 with stiff-man syndrome. J Clin Endocrinol Metab 1993;77:1550-1553.
51. Dalakas MC, Fujii M, Li M, McElroy B: The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000;55:1531-1535.
52. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM: Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-1020.
53. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-1560.
54. Raju R, Rakocevic G, Chen Z, Hoehn G, Semino-Mora C, Shi W, Olsen R, Dalakas MC: Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006;129:3270-3276.
55. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W: Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998;44:194-201.
56. Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H: Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999;46:263-267.
57. Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H: Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 2000;175:40-44.
58. Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, Yaguchi M, Ishida K, Shoji M, Tanaka M, Mizusawa H, Okamoto K: Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 2001;70:386-389.
59. Vianello M, Bisson G, Dal Maschio M, Vassanelli S, Girardi S, Mucignat C, Fountzoulas K, Giometto B: Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-GAD antibodies. Autoimmunity 2008;41:66-73.
60. Rakocevic G, Raju R, Dalakas MC: Anti-glutamic acid decarboxylase antibodies in the serum and cere-brospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol 2004;61:902-904.
61. Essalmi L, Meaux-Ruault N, Hafsaoui C, Gil H, Curlier E, Dupond JL: Stiff person syndrome associated with thymoma. Efficacy of thymectomy. Rev Med Interne 2007;28:627-630.
62. Dropcho EJ: Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol 1996;39:659-667.
63. Nguyen-Huu BK, Urban P P, Schreckenberger M, Dieterich M, Werhahn KJ: Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer. Mov Disord 2006;21:1285-1287.
64. Folli F, Solimena M, Cofiell R, Austoni M, Tallini G, Fassetta G, Bates D, Cartlidge N, Bottazzo GF, Piccolo G, et al: Autoantibodies to a 128-kD synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med 1993;328:546-551.
65. De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, Piccolo G, Meinck HM, Austoni M, Fassetta G, Bottazzo G, et al: The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993;178:2219-2223.
66. Rosin L, DeCamilli P, Butler M, Solimena M, Schmitt H P, Morgenthaler N, Meinck HM: Stiff-man syndrome in a woman with breast cancer: an uncommon central nervous system paraneoplastic syndrome. Neurology 1998;50:94-98.
67. Wessig C, Klein R, Schneider MF, Toyka K V, Naumann M, Sommer C: Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology 2003;61:195-198.
68. McCabe DJ, Turner NC, Chao D, Leff A, Gregson NA, Womersley HJ, Mak I, Perkin GD, Schapira AH: Paraneoplastic 'stiff person syndrome' with metastatic adenocarcinoma and anti-Ri antibodies. Neurology 2004;62:1402-1404.
69. Butler MH, Hayashi A, Ohkoshi N, Villmann C, Becker CM, Feng G, De Camilli P, Solimena M: Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000;26:307-312.
70. Silverman IE: Paraneoplastic stiff limb syndrome. J Neurol Neurosurg Psychiatry 1999;67:126-127.
71. Schiff D, Dalmau J, Myers DJ: Anti-GAD antibody positive stiff-limb syndrome in multiple myeloma. J Neurooncol 2003;65:173-175.
72. Clow EC, Couban S, Grant IA: Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation. Muscle Nerve 2008;38:1649-1652.
73. McHugh JC, Murray B, Renganathan R, Connolly S, Lynch T: GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord 2007;22:1343-1346.
74. Hassin-Baer S, Kirson ED, Shulman L, Buchman AS, Bin H, Hindiyeh M, Markevich L, Mendelson E: Stiff-person syndrome following West Nile fever. Arch Neurol 2004;61:938-941.
75. Chroni E, Sakkis T, Georgiou S, Monastirli A, Pasmatzi E, Paschalis C, Tsambaos D: Stiff-person syndrome associated with oral isotretinoin treatment. Neuromuscul Disord 2002;12:886-888.
76. Ellis CN, Gilbert M, Cohen KA, Albers J W, Ball RD, Albin RL, Silverman A, Voorhees JJ: Increased muscle tone during etretinate therapy. J Am Acad Dermatol 1986;14:907-909.
77. Albin RL, Silverman AK, Ellis CN, Voorhees JJ, Albers JW: A new syndrome of axial muscle rigidity associated with etretinate therapy. Mov Disord 1988;3:70-76.
78. Martino G, Grimaldi LM, Bazzigaluppi E, Passini N, Sinigaglia F, Rogge L: The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients. J Neuroimmunol 1996;69:129-134.
79. Dinkel K, Rickert M, Moller G, Adamski J, Meinck HM, Richter W: Stiff-man syndrome: identification of 17 beta-hydroxysteroid dehydrogenase type 4 as a novel 80-kDa antineuronal antigen. J Neuroimmunol 2002;130:184-193.
80. Sommer C, Weishaupt A, Brinkhoff J, Biko L, Wessig C, Gold R, Toyka KV: Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IGG antibodies to amphiphysin. Lancet 2005;365:1406-1411.
81. Nemni R, Caniatti LM, Gironi M, Bazzigaluppi E, De Grandis D: Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology 2004;62:2101-2102.
82. Dalakas MC, Li M, Fujii M, Jacobowitz DM: Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001;57:780-784.
83. Dalakas MC: B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Pharmacol Ther 2006;112:57-70.
84. Raju R, Hampe CS: Immunobiology of stiff-person syndrome. Int Rev Immunol 2008;27:79-92.
85. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F: Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089-1104.
86. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxy-lase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94:2125-2129.
87. Hiemstra HS, Schloot NC, van Veelen PA, Willemen SJ, Franken KL, van Rood JJ, de Vries RR, Chaudhuri A, Behan PO, Drijfhout J W, Roep BO: Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001;98:3988-3991.
88. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E: Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 1978;271:67-69.
89. Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A: The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dys-regulation and/or cell damage. J Autoimmun 1996;9:295-300.
90. Zack DJ, Stempniak M, Wong AL, Taylor C, Weisbart RH: Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoanti-body. J Immunol 1996;157:2082-2088.
91. Yanase K, Smith RM, Puccetti A, Jarett L, Madaio MP: Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest 1997;100:25-31.
92. Wenthold RJ, Skaggs KK, Reale RR: Retrograde axonal transport of antibodies to synaptic membrane components. Brain Res 1984;304:162-165.
93. Ternynck T, Avrameas A, Ragimbeau J, Buttin G, Avrameas S: Immunochemical, structural and translocating properties of anti-DNA antibodies from (NZBxNZW)F1 mice. J Autoimmun 1998;11: 511-521.
94. Avrameas A, Ternynck T, Nato F, Buttin G, Avrameas S: Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracyto-plasmic and intranuclear translocation of macro-molecules. Proc Natl Acad Sci USA 1998;95: 5601-5606.
95. De Coupade C, Fittipaldi A, Chagnas V, Michel M, Carlier S, Tasciotti E, Darmon A, Ravel D, Kearsey J, Giacca M, Cailler F: Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem J 2005;390:407-418.
96. Deutsch M, Guejes L, Zurgil N, Shovman O, Gilburd B, Afrimzon E, Shoenfeld Y: Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis. Clin Exp Rheumatol 2004;22:S35-S40.
97. Gilligan HM, Bredy B, Brady HR, Hebert MJ, Slayter HS, Xu Y, Rauch J, Shia MA, Koh JS, Levine JS: Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996;184:2231-2241.
98. Vasconcelos OM, Dalakas MC: Stiff-person syndrome. Curr Treat Options Neurol 2003;5:79-90.
99. Ruegg SJ, Steck AJ, Fuhr P: Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome. Neurology 2004;62:338.
100. Hattan E, Angle MR, Chalk C: Unexpected benefit of propofol in stiff-person syndrome. Neurology 2008;70:1641-1642.
101. Silbert PL, Matsumoto JY, McManis PG, Stolp-Smith KA, Elliott BA, McEvoy KM: Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology 1995;45: 1893-1897.
102. Stayer C, Tronnier V, Dressnandt J, Mauch E, Marquardt G, Rieke K, Muller-Schwefe G, Schumm F, Meinck HM: Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology 1997;49:1591-1597.
103. Liguori R, Cordivari C, Lugaresi E, Montagna P: Botulinum toxin A improves muscle spasms and rigidity in stiff-person syndrome. Mov Disord 1997; 12:1060-1063.
104. Mori Y, Kawai K, Morishige Y, Uchida K, Yamamoto T, Sakabe T, Kawai M: Variant form of stiff-man syndrome with neck pain: report of a case treated with muscle afferent block. J Anesth 2000;14:207-210.
105. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B: High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001;345:1870-1876.
106. Brashear HR, Phillips LH 2nd: Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 1991;41:1588-1592.
107. Baker MR, Das M, Isaacs J, Fawcett PR, Bates D: Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatry 2005;76:999-1001.
108. Saidha S, Elamin M, Mullins G, Chaila E, Tormey VJ, Hennessy MJ: Treatment of progressive encephalomyelitis with rigidity and myoclonic jerks with rituximab: a case report. Eur J Neurol 2008;15:e33.
109. Brown P, Rothwell JC, Marsden CD: The stiff leg syndrome. J Neurol Neurosurg Psychiatry 1997;62: 31-37.
110. Saiz A, Graus F, Valldeoriola F, Valls-Sole J, Tolosa E: Stiff-leg syndrome: a focal form of stiff-man syndrome. Ann Neurol 1998;43:400-403.
111. Fiol M, Cammarota A, Rivero A, Pardal A, Nogues M, Correale J: Focal stiff-person syndrome. Neurologia 2001;16:89-91.
112. Shiraishi H, Motomura M, Iwanaga H, Tsujino A, Nishiura Y, Shirabe S, Nakamura T, Yoshimura T: Successful treatment in a patient with a focal form of stiff-person syndrome using plasma exchange and intravenous immunoglobulin therapy. Rinsho Shinkeigaku 2002;42:766-770.
113. Roobol TH, Kazzaz BA, Vecht CHJ: Segmental rigidity and spinal myoclonus as a paraneoplastic syndrome. J Neurol Neurosurg Psychiatry 1987;50:628-631.
114. Guilleminault C, Sigwald J, Castaigne P: Sleep studies and therapeutic trial with L-dopa in a case of stiff-man syndrome. Eur Neurol 1973;10:89-96
115. Martinelli P, Pazzaglia P, Montagna P, Coccagna G, Rizzuto N, Simonati S, Lugaresi E: Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry 1978;41: 458-462.
116. Leigh PN, Rothwell JC, Traub M, Marsden CD: A patient with reflex myoclonus and muscle rigidity: 'jerking stiff-man syndrome'. J Neurol Neurosurg Psychiatry 1980;43:1125-1131.
117. Alberca R, Romero M, Chaparro J: Jerking stiff-man syndrome. J Neurol Neurosurg Psychiatry 1982;45: 1159-1160.
118. Giometto B, Miotto D, Faresin F, Argentiero V, Scaravilli T, Tavolato B: Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci 1996;143:57-59.
119. Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A: Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med 2001;40:968-971.
120. Rakocevic G, Raju R, Semino-Mora C, Dalakas MC: Stiff person syndrome with cerebellar disease and high-titer anti-gad antibodies. Neurology 2006;67: 1068-1070.
121. Chia SY, Chua R, Lo YL, Wong MC, Chan LL, Tan EK: Acute ataxia, Graves' disease, and stiff person syndrome. Mov Disord 2007;22:1969-1971.
122. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F: Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-1030.
123. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F: Cerebellar ataxia with antiglutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001;58:225-230.
124. Vulliemoz S, Vanini G, Truffert A, Chizzolini C, Seeck M: Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry 2007;78:187-189.
125. Matsumoto S, Kusuhara T, Nakajima M, Ouma S, Takahashi M, Yamada T: Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies. J Neurol Neurosurg Psychiatry 2002;73:345-346.
126. Campbell AMG, Garland H: Subacute myoclonic spinal neuronitis. J Neurol Neurosurg Psychiatry 1956;19:268-274.
127. Whiteley AM, Swash M, Urich H: Progressive encephalomyelitis with rigidity. Brain 1976;99:27-42.
128. Kasperek S, Zebrowski S: Stiff-man syndrome and encephalomyelitis. Report of a case. Arch Neurol 1971;24:22-30.
129. Lhermitte F, Chain F, Escourolle R, Chedru F, Guilleminault C, Francoual M: A further case of tetanus-like contracture distinct from the stiff man syndrome. Pharmacological and neuropathological study of a case of predominantly spinal encephalomyelitis. Rev Neurol (Paris) 1973;128:3-21.
130. Howell DA, Lees AJ, Toghill PJ: Spinal internuncial neurones in progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1979;42:773-785.
131. Burn DJ, Ball J, Lees AJ, Behan PO, Morgan-Hughes JA: A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid decarboxy-lase antibodies. J Neurol Neurosurg Psychiatry 1991;54:449-451.
132. Casado JL, Gil-Peralta A, Graus F, Arenas C, Lopez JM, Alberca R: Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity. Neurology 1994;44:1521-1522.
133. Back T, Stoltenburg-Didinger G, Ploner CJ, Meisel H, Zschenderlein R: A new variant of progressive encephalomyelitis with rigidity associated with cer-ebellar ataxia and dementia: correlation of MRI and histopathological changes. A case report. Neurol Res 1997;19:187-191.
134. Gouider-Khouja N, Mekaouar A, Larnaout A, Miladi N, Ben Khelifa F, Hentati F: Progressive encephalomyelitis with rigidity presenting as a stiff-person syndrome. Parkinsonism Relat Disord 2002; 8:285-288.
135. Warren JD, Scott G, Blumbergs PC, Thompson PD: Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-gad antibodies. J Clin Neurosci 2002;9:328-329.
136. Kikuchi N, Nomura A, Ishii Y, Sekizawa K, Harada H, Ishii K, Wada T: Progressive encephalomyelitis with rigidity as refractory asthma. Thorax 2003;58: 645.
137. Spitz M, Ferraz HB, Barsottini OG, Gabbai AA: Progressive encephalomyelitis with rigidity: a para-neoplastic presentation of oat cell carcinoma of the lung. Case report. Arq Neuropsiquiatr 2004;62:547-549.
138. Kraemer M, Berlit P: Progressive encephalomyelitis with rigidity and myoclonus in an 81-year-old patient. Clin Neurol Neurosurg 2008;110:279-281.